PortfoliosLab logoPortfoliosLab logo
ASPI vs. AYTU
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ASPI vs. AYTU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ASP Isotopes Inc. Common Stock (ASPI) and Aytu BioPharma, Inc. (AYTU). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ASPI achieves a 41.12% return, which is significantly higher than AYTU's -19.62% return.


ASPI

1D
-9.36%
1M
46.32%
YTD
41.12%
6M
31.76%
1Y
-4.79%
3Y*
175.06%
5Y*
10Y*

AYTU

1D
-0.48%
1M
-18.04%
YTD
-19.62%
6M
-1.88%
1Y
34.84%
3Y*
4.72%
5Y*
-54.43%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ASPI vs. AYTU - Yearly Performance Comparison


2026 (YTD)2025202420232022
ASPI
ASP Isotopes Inc. Common Stock
41.12%18.10%153.07%13.29%-40.82%
AYTU
Aytu BioPharma, Inc.
-19.62%52.94%-40.14%-24.87%18.42%

Correlation

The correlation between ASPI and AYTU is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.22

Correlation (3Y)
Calculated over the trailing 3-year period

0.05

Correlation (All Time)
Calculated using the full available price history since Nov 11, 2022

0.07

The correlation between ASPI and AYTU shifts across timeframes, from 0.05 (3 years) to 0.22 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ASPI:

$706.81M

AYTU:

$21.97M

EPS

ASPI:

-$2.06

AYTU:

-$2.91

PS Ratio

ASPI:

26.93

AYTU:

0.43

PB Ratio

ASPI:

3.46

AYTU:

0.63

Total Revenue (TTM)

ASPI:

$23.85M

AYTU:

$56.60M

Gross Profit (TTM)

ASPI:

$2.47M

AYTU:

$36.14M

EBITDA (TTM)

ASPI:

-$118.78M

AYTU:

-$27.34M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ASPI vs. AYTU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ASPI
ASPI Risk / Return Rank: 4242
Overall Rank
ASPI Sharpe Ratio Rank: 3939
Sharpe Ratio Rank
ASPI Sortino Ratio Rank: 4949
Sortino Ratio Rank
ASPI Omega Ratio Rank: 4545
Omega Ratio Rank
ASPI Calmar Ratio Rank: 3838
Calmar Ratio Rank
ASPI Martin Ratio Rank: 3838
Martin Ratio Rank

AYTU
AYTU Risk / Return Rank: 6060
Overall Rank
AYTU Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
AYTU Sortino Ratio Rank: 6060
Sortino Ratio Rank
AYTU Omega Ratio Rank: 6060
Omega Ratio Rank
AYTU Calmar Ratio Rank: 6161
Calmar Ratio Rank
AYTU Martin Ratio Rank: 6262
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ASPI vs. AYTU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ASP Isotopes Inc. Common Stock (ASPI) and Aytu BioPharma, Inc. (AYTU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ASPIAYTUDifference

Sharpe ratio

Return per unit of total volatility

-0.04

0.54

-0.58

Sortino ratio

Return per unit of downside risk

0.77

1.29

-0.52

Omega ratio

Gain probability vs. loss probability

1.08

1.16

-0.08

Calmar ratio

Return relative to maximum drawdown

-0.07

0.99

-1.05

Martin ratio

Return relative to average drawdown

-0.11

2.38

-2.48

ASPI vs. AYTU - Sharpe Ratio Comparison

The current ASPI Sharpe Ratio is -0.04, which is lower than the AYTU Sharpe Ratio of 0.54. The chart below compares the historical Sharpe Ratios of ASPI and AYTU, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ASPIAYTUDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.04

0.54

-0.58

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.64

Sharpe Ratio (All Time)

Calculated using the full available price history

0.31

-0.36

+0.67

Drawdowns

ASPI vs. AYTU - Drawdown Comparison

The maximum ASPI drawdown since its inception was -88.57%, smaller than the maximum AYTU drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for ASPI and AYTU.


Loading charts...

Drawdown Indicators


ASPIAYTUDifference

Max Drawdown

Largest peak-to-trough decline

-88.57%

-100.00%

+11.43%

Max Drawdown (1Y)

Largest decline over 1 year

-71.03%

-35.47%

-35.56%

Max Drawdown (3Y)

Largest decline over 3 years

-71.03%

-70.24%

-0.79%

Max Drawdown (5Y)

Largest decline over 5 years

-99.12%

Current Drawdown

Current decline from peak

-46.26%

-100.00%

+53.74%

Average Drawdown

Average peak-to-trough decline

-41.69%

-95.14%

+53.45%

Ulcer Index

Depth and duration of drawdowns from previous peaks

45.53%

14.70%

+30.83%

Volatility

ASPI vs. AYTU - Volatility Comparison

ASP Isotopes Inc. Common Stock (ASPI) has a higher volatility of 39.04% compared to Aytu BioPharma, Inc. (AYTU) at 12.46%. This indicates that ASPI's price experiences larger fluctuations and is considered to be riskier than AYTU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ASPIAYTUDifference

Volatility (1M)

Calculated over the trailing 1-month period

39.04%

12.46%

+26.58%

Volatility (6M)

Calculated over the trailing 6-month period

73.84%

33.42%

+40.42%

Volatility (1Y)

Calculated over the trailing 1-year period

108.47%

66.08%

+42.39%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

112.09%

85.63%

+26.46%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

112.09%

188.31%

-76.22%

Dividends

ASPI vs. AYTU - Dividend Comparison

Neither ASPI nor AYTU has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ASPI vs. AYTU - Financials Comparison

This section allows you to compare key financial metrics between ASP Isotopes Inc. Common Stock and Aytu BioPharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M25.00M30.00M35.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
16.66M
12.41M
(ASPI) Total Revenue
(AYTU) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ASPI and AYTU have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ASPI has higher volatility (39.04%) compared to AYTU (12.46%). In terms of maximum drawdown, ASPI dropped -88.57% vs AYTU's -100.00%.

AYTU currently has the higher Sharpe Ratio (0.54 vs -0.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ASPI and AYTU

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer